Journals / Turkish Neurosurgery / 2013 / Cilt: 23 - Sayı: 2

Dif üz Aksonal Yaralanma Hastalarının Serumunda TGF β1, IL-8 ve Nitrik Oksit Değerlendirilmesi ve Klinik Durum ve Sonuç ile İlişkileri

evaluation of TGF β1, IL-8 and Nitric Oxide in the Serum of Diffuse Axonal Inj ury Patients and Its Association with Clinical Status and Outcome

Pages
151–154
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

TGF β1 could protect the brain from cytotoxics, hypoxia and acidosis so its level comes down in brain inj uries as a result of its overuse.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: The aim was to evaluate the level of interleukin 8 (IL-8), transforming growth factor β1 (TGF β1) and Nitric oxide (NO) in diffuse axonal inj ury (DAI) and its association to the outcome and clinical status. mAterIAl and methOds: This cross-sectional study was conducted on 20 patients with DAI and 20 patients with multiple traumas without head inj ury and 20 healthy subjects as controls.
📊
Key Findings & Data:Blood levels of IL-8, TGF β1 and nitric oxide in the 1st, 2nd, 3rd and 7th days of inj ury were measured.
💡
Conclusion & Impact:TGF β1 could protect the brain from cytotoxics, hypoxia and acidosis so its level comes down in brain inj uries as a result of its overuse.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: The aim was to evaluate the level of interleukin 8 (IL-8), transforming growth factor β1 (TGF β1) and Nitric oxide (NO) in diffuse axonal inj ury (DAI) and its association to the outcome and clinical status. mAterIAl and methOds: This cross-sectional study was conducted on 20 patients with DAI and 20 patients with multiple traumas without head inj ury and 20 healthy subjects as controls. Blood levels of IL-8, TGF β1 and nitric oxide in the 1st, 2nd, 3rd and 7th days of inj ury were measured. Glasgow coma scale (GCS) of patients was recorded. The patients outcome was evaluated by Glasgow Outcome Scale (GOS). results: The level of TGF β1 was increasing during the admission and had the maximum level at the 7th day. In the DAI group, there was significant correlation between GOS score and serum IL-8 at 7th day of admission (r=-0.68, p= 0.002). In this group the GCS was found to be significantly correlated with the IL-8 concentration at 7th day of admission (p= 0.026, r=-0.55). COnClusIOn: IL-8 has negative correlation with GCS and GOS. TGF β1 could protect the brain from cytotoxics, hypoxia and acidosis so its level comes down in brain inj uries as a result of its overuse.

Özet

AMAÇ: Burada amaç difüz aksonal yaralanmada (DAY) interlökin 8 (IL-8), transforme edici büyüme faktörü β1 (TGF β1) ve Nitrik oksit (NO) düzeyini ve sonuç ve klinik durumla ilişkisini değerlendirmekti. yÖntem ve GereÇler: Bu çapraz kesitsel çalışma, 20 DAY hastasında, 20 kafa yaralanması olmadan çoklu travma hastasında ve kontrol olarak 20 sağlıklı kişide gerçekleştirildi. Yaralanmadan 1, 2, 3 ve 7 gün sonra kanda IL-8, TGF β1 ve nitrik oksit düzeyleri ölçüldü. Hastaların Glasgow koma ölçeği (GCS) değerleri kaydedildi. Hastaların sonucu Glasgow Sonuç Ölçeği (GOS) ile değerlendirildi. BulGulAr: TGF β1 düzeyi hastaneye yatışla birlikte artıyordu ve maksimum düzeye 7. günde ulaştı. DAY grubunda GOS skoru ile yattıktan sonraki 7. gün serum IL-8 değeri arasında anlamlı bir korelasyon vardı (r=-0,68, p= 0,002). Bu grupta GCSnin yattıktan sonra 7. günde IL-8 konsantrasyonuyla önemli ölçüde korelasyon gösterdiği bulundu (p= 0,026, r=-0,55). sOnuÇ: IL-8in GCS ve GOS ile negatif korelasyonu vardır. TGF β1 beyni sitotoksik maddeler, hipoksi ve asidozdan koruyabilir ve bu nedenle beyin yaralanmalarında fazla kullanılmasıyla düzeyi düşer.

🔖

Cite This Article

SOHREVARDI, S. M., AHMADINEJAD, M., SALD, K., SARAFZADEH, F., ZADEH, S. S., YOUSEFI, M., SAVARI, O. (2013). Dif üz Aksonal Yaralanma Hastalarının Serumunda TGF β1, IL-8 ve Nitrik Oksit Değerlendirilmesi ve Klinik Durum ve Sonuç ile İlişkileri. Turkish Neurosurgery, Cilt: 23 - Sayı: 2, 151–154. https://ajindex.com/articles/404965

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Barone FC, Feuerstein GZ: Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab19: 819-834, l999 2. Buttram SDW, Wisnewski SR, Jackson EK, Adelson PD, Feldman K, Bayir H, Berger RP, Clark RSB, Kochanek PM: Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid flowing severe pediatric traumatic brain inj ury: Effects of moderate hypothermia. J Neurotrauma 24:1707–1717, 2007 3. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T: IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain inj ury: Relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol 101: 211-221, 1999 4. Diestel A, Roessler J, Berger F, Schmitt KRL: Hypothermia down regulates inflammation but enhances IL-6 secretion by stimulated endothelial cells. Cryobiology 57:216–222, 2008 5. Dziedzic T, Bartus S, Klimkowicz A, Motyl M, Slowik A, Szczudlik A: Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke 33:2334-2335, 2002 6. Fries M, Stoppe C, Brucken D, Rossaint R, Kuhlen R: Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest. J Crit Care 24:453–457, 2009 7. He LM, Qiu BH, Qi ST, Fang LX, Liu XJ: Dynamic changes of serum interleukin-6 and interleukin-8 in patients with acute traumatic brain inj ury and the clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 29: 999-1001, 2009 8. Hlatky R, Furuya Y, Valadka AB, Goodman JC, Robertson CS: Microdialysate nitrate/nitrite levels following severe head inj ury. Acta Neurochir Suppl 81:331-333, 2002 9. Hlatky R, Goodman JC, Valadka AB, Robertson CS: Role of nitric oxide in cerebral blood flow abnormalities after traumatic brain inj ury. J Cereb Blood Flow Metab 23:582-588, 2003 10. Kim JS, Yoon SS, Kim YH, Ryu JS: Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 27:1553-1557, l996 11. Kostulas N, Pelidou SH, Kivisakk P, Kostulas V, Link H: Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30:2174-2179, 1999 12. Logan A, Frautschy SA, Gonzalez AM, Sporn MB, Baird A: Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral inj ury. Brain Res 587: 216-225, l992 13. Maier B, Schwerdtfege